We are live on ! Find out more
ACIU icon

AC Immune
ACIU

18 hedge funds and large institutions have $117M invested in AC Immune in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

0.04% more ownership

Funds ownership: 19.63% → 19.67% (+0.04%)

18% less funds holding

Funds holding: 22 → 18 (-4)

18% less capital invested

Capital invested by funds: $143M → $117M (-$26.3M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
+$1.22M
2
Renaissance Technologies
Renaissance Technologies
New York
+$831K
3
Deutsche Bank
Deutsche Bank
Germany
+$673K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$141K
5
VF
Virtu Financial
New York
+$124K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$752K
2
BAM
Belpointe Asset Management
Nevada
-$650K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$206K
4
Wells Fargo
Wells Fargo
California
-$127K
5
Barclays
Barclays
United Kingdom
-$57.2K

ACIU Hedge Fund Activity: Q1 2018 in Review

18 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2018, worth a combined $117M — down 18% from $143M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ACIU and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 8 added.

The largest buyer was Artal Group, adding an estimated $1.22M. The largest seller was Citadel Advisors, cutting an estimated $752K.

  • 18 institutional investors held AC Immune (ACIU) as of Q1 2018, down from 22 in Q4 2017.
  • Funds reported $117M of AC Immune stock for Q1 2018, down 18% quarter-over-quarter.
  • 1 fund opened new AC Immune positions in Q1 2018 and 5 closed out, a net change of -4 holders.
  • The largest AC Immune buyer in Q1 2018 was Artal Group, an estimated $1.22M added.
  • The largest AC Immune seller in Q1 2018 was Citadel Advisors, an estimated $752K sold.

Based on aggregated 13F filings for Q1 2018.